Search - tctmd.com

Displaying 601 - 620 of 620

Sort: Relevancy | Date

News Daily News

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

L.A. McKeown

January 09, 2017

Presentation

Culprit Vessel vs Multivessel vs In-Hospital Staged PCI for STEMI and Multivessel Disease

Presenter: M.B. Iqbal

January 09, 2017

News Daily News

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Todd Neale

January 06, 2017

Presentation Cardiovascular Interventions 2016

Precision PCI

Presenter: Richard Shlofmitz

November 11, 2016

Presentation Cardiovascular Interventions 2016

Understanding the ABSORB Bioresorbable Vascular Scaffold: The Next Revolution in PCI

Presenter: David G. Rizik

November 10, 2016

Presentation Cardiovascular Interventions 2016

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Presenter: James Hermiller

November 08, 2016

Presentation TEACH 2016

Hemodynamics Principles Underlying Mechanical Circulatory Support during High Risk PCI

Presenter: William O'Niel

October 29, 2016

Presentation CCVVC 2016

Anti-Thrombotic Therapy for PCI

Presenter: Deepak L. Bhatt

June 16, 2016

News Daily News

EVEREST: MitraClip Safe, Effective for Mitral Valve Repair

TCT Daily Staff

September 23, 2009

News Daily News

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

Kim Dalton

August 30, 2009

News Daily News

FAME Published: FFR Guidance Improves Outcomes in Multivessel Disease

Kim Dalton

January 14, 2009

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

Partner Content

Registration - Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

December 4, 2017

Partner Content

Registration: Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

December 4, 2017

CME

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

Partner Content

Registration: What’s Next for Left Main PCI?

April 7, 2017

CME

What’s Next for Left Main PCI?

CME

Advertisement

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

Culprit Vessel vs Multivessel vs In-Hospital Staged PCI for STEMI and Multivessel Disease

Readmissions After TAVR Common, With Most Due to Noncardiac Reasons

Precision PCI

Understanding the ABSORB Bioresorbable Vascular Scaffold: The Next Revolution in PCI

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Hemodynamics Principles Underlying Mechanical Circulatory Support during High Risk PCI

Anti-Thrombotic Therapy for PCI

EVEREST: MitraClip Safe, Effective for Mitral Valve Repair

Ticagrelor More Effective Than Clopidogrel in ACS-With No Extra Bleeding

FAME Published: FFR Guidance Improves Outcomes in Multivessel Disease

Changing Course with Anticoagulation in Secondary Prevention of CAD

Registration - Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Registration: Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

Registration: What’s Next for Left Main PCI?

What’s Next for Left Main PCI?

Latest Data on Left Main Stenting and its Implications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content